MediciNova, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNOV research report →
Companywww.medicinova.com
MediciNova, Inc. , a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction.
- CEO
- Yuichi Iwaki
- IPO
- 2006
- Employees
- 13
- HQ
- La Jolla, CA, US
Price Chart
Valuation
- Market Cap
- $68.42M
- P/E
- -5.84
- P/S
- 114.67
- P/B
- 0.00
- EV/EBITDA
- 2146.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 15.20%
- Op Margin
- -2164.84%
- Net Margin
- -1964.35%
- ROE
- -0.12%
- ROIC
- -0.03%
Growth & Income
- Revenue
- $409.66K · 0.00%
- Net Income
- $-11,997,957 · -8.58%
- EPS
- $-0.24 · -4.35%
- Op Income
- $-13,283,000
- FCF YoY
- 7.83%
Performance & Tape
- 52W High
- $1.96
- 52W Low
- $1.17
- 50D MA
- $1.41
- 200D MA
- $1.41
- Beta
- 0.63
- Avg Volume
- 45.15K
Get TickerSpark's AI analysis on MNOV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 16, 26 | Matsuda Kazuko | other | 350,000 |
| Jan 16, 26 | IWAKI YUICHI | other | 450,000 |
| Jun 17, 25 | Nagao Hideki | other | 20,000 |
| Jun 17, 25 | Lemerond Nicole | other | 20,000 |
| Jun 17, 25 | BEAVER CAROLYN | other | 20,000 |
| Feb 12, 25 | Nagao Hideki | other | 24,500 |
| Feb 12, 25 | Matsuda Kazuko | other | 100,000 |
| Feb 12, 25 | Lemerond Nicole | other | 24,500 |
| Feb 12, 25 | IWAKI YUICHI | other | 100,000 |
| Feb 12, 25 | BEAVER CAROLYN | other | 24,500 |
Our MNOV Coverage
We haven't published any research on MNOV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MNOV Report →